Edinburgh University scientists awarded £46.3m for research into ‘dark genome’

The funding has been awarded by the Medical Research Council.
Edinburgh Unviersity Scientists have been awarded £46.3 million for research which will examine previously under-researched parts of DNA (Lauren Hurley/PA)
Katrine Bussey24 July 2023

Scientists at a Scottish university have been awarded more than £40 million for work which will include research into the so-called dark genome.

A total of £46.3 million has been awarded by the Medical Research Council (MRC) to the MRC Human Genetics Unit at Edinburgh University.

With the work to include research into the 98% of DNA which is underexplored, scientists said their work could ultimately help people living with genetic conditions and cancer.

The five-year funding will support research into this dark genome – which was previously referred to as “junk” DNA.

But its is hoped this work could help provide new insights into complex genetic diseases.

Scientists will use collaborative research and new techniques to explore these understudied areas of DNA in a bid to develop further the  understanding of human genetic disease.

Since the human genome was first sequenced in 2003, research has mainly focused on parts of DNA that contain instructions for making proteins – the fundamental building blocks of all organisms.

However, these account for only 2% of the three billion letters that make up the human genome.

The MRC funding, which represents a significant investment in UK genomics research, will enable scientists to focus on the remaining parts of DNA.

Professor Wendy Bickmore, director of the MRC Human Genetics Unit at the University of Edinburgh, said: “It’s exciting that we now have so much human genome sequence data, but we need to turn that data into knowledge about how our genome works in health and disease.

“This new funding will enable us to tackle that challenge together, harnessing experimental and computational expertise to better understand, manage and treat disease and, ultimately, improve the lives of people living with genetic conditions and cancers.”

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in